These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 6157542)

  • 21. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
    Fischer DG; Golightly MG; Koren HS
    J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the inhibition of macrophage migration induced by soluble antigen-antibody complexes.
    Kotkes P; Pick E
    Clin Exp Immunol; 1975 Jan; 19(1):105-20. PubMed ID: 54230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular co-operation in the production of human leucocyte inhibitory factor by lymphocyte subpopulations stimulated with antigens and allogeneic cells.
    Räsänen L
    Immunology; 1979 Aug; 37(4):715-21. PubMed ID: 387577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
    Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
    Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
    Lee KC; Berry D
    J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytes.
    Philp JR; McCormack JG; Moore AL; Johnson JE
    J Immunol; 1981 Apr; 126(4):1469-72. PubMed ID: 7009741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ly phenotype of lymphocytes producing murine migration inhibitory factor (MIF).
    Kühner AL; Cantor H; David JR
    J Immunol; 1980 Sep; 125(3):1117-9. PubMed ID: 6997376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption of macrophage aggregating factor by guinea-pig peritoneal exudate cells.
    Badenoch-Jones P; Rouveix B; Turk JL
    Immunology; 1981 May; 43(1):67-73. PubMed ID: 7251051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection.
    Yamamoto Y; Klein TW; Newton C; Friedman H
    J Immunol; 1992 Jan; 148(2):584-9. PubMed ID: 1729375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective chemotaxis of Ia antigen-positive blood monocytes in response to a macrophage chemotactic lymphokine extractable from PPD-induced delayed hypersensitivity reaction site in guinea-pigs.
    Yoshimura T; Honda M; Hayashi H
    Immunology; 1984 Jun; 52(2):269-80. PubMed ID: 6588023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposing effects of cryostat sections of preneoplastic and neoplastic mouse mammary lesions on in vitro migration of peritoneal exudate cells.
    Wei WZ; Miller FR; Blazar BA; Medina D; Heppner G
    J Immunol; 1979 May; 122(5):2059-67. PubMed ID: 448117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.
    Weiss L; Glaves D
    J Immunol; 1975 Nov; 115(5):1362-5. PubMed ID: 1100729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.